Results 211 to 220 of about 940,829 (402)
Effect of Telmisartan on Ambulatory Blood Pressure Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of Serum Albumin in Hemodialysis Patients [PDF]
Hidetaka Shimada +9 more
openalex +1 more source
Antibacterial efficacy of metals in preventative and therapeutic equine podiatry applications
Summary Background Thrush, abscesses, white line disease and cankers are life‐threatening infections common in equine hooves. Copper has a history of medicinal use on equine hooves. There is a paucity of scientific evidence supporting the use of metals as antimicrobial agents in equine podiatry.
J. E. Caughron +2 more
wiley +1 more source
Identification and prognosis of low office and ambulatory blood pressure in patients with heart failure. [PDF]
Li Z +9 more
europepmc +1 more source
Albuminuria in diabetes mellitusRelation to ambulatory versus office blood pressure and effects of cilazapril [PDF]
Bernard Waeber +3 more
openalex +1 more source
Abstract Background Antimicrobial resistance (AMR) is an increasingly serious threat to human and animal health. Antimicrobial use (AMU) in horses is gathering research interest, although there remain significant evidence gaps. Currently, there is scant qualitative research into equine owners' use of antimicrobials, specifically antibiotics, hindering ...
Rebekah B. Stuart +3 more
wiley +1 more source
Impact of Office and Ambulatory Blood Pressure on Mortality in Patients with Coronary Heart Disease. [PDF]
de la Sierra A +4 more
europepmc +1 more source
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik +2 more
wiley +1 more source
Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension. [PDF]
Schlaich MP +6 more
europepmc +1 more source

